Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Btrcem1/Cya
Common Name:
Btrc-KO
Product ID:
S-KO-01261
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Btrc-KO
Strain ID
KOCMP-12234-Btrc-B6J-VA
Gene Name
Btrc
Product ID
S-KO-01261
Gene Alias
Beta-Trcp1; E3RS-IkappaB; E3RSIkappaB; FWD1; Fbw1a; HOS; SCF b-TRCP; Slimb; b-TrCP; beta-TrCP
Background
C57BL/6JCya
NCBI ID
12234
Modification
Conventional knockout
Chromosome
19
Phenotype
MGI:1338871
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Btrcem1/Cya mice (Catalog S-KO-01261) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000065601
NCBI RefSeq
NM_001037758.2
Target Region
Exon 5
Size of Effective Region
~1.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Btrc, also known as beta-transducin repeat containing E3 ubiquitin protein ligase, is an E3 ubiquitin ligase. It plays a crucial role in the ubiquitination and proteasomal degradation of target proteins, thereby regulating various cellular processes. It is involved in multiple pathways, such as the NF-κB pathway by targeting IκBα for degradation, and is important for maintaining normal cellular functions and homeostasis [4].

In a Chinese family with split hand/foot malformation type 3, a 120 kb microduplication containing only Btrc was identified. The transcription levels of Btrc mRNA in the proband's lymphocyte were significantly higher than in healthy controls, suggesting that abnormal Btrc expression may cause limb malformation [1]. In breast cancer, phosphorylation of ULK1 by MAPK1/3 kinase triggers its interaction with Btrc and subsequent degradation, attenuating mitophagy and promoting bone metastasis [2]. In hepatic steatosis models, Btrc was upregulated, negatively correlated with decreased ATGL levels, and identified as the E3 ligase for ATGL. Knockdown of Btrc ameliorated steatosis [3]. In triple-negative breast cancer, WBP2 promotes Btrc mRNA stability, enhancing cell migration and invasion via NF-κB activation [4]. In osteosarcoma, lnc-SELPLG-2:1 activates oncogenesis through the hsa-miR-10a-5p/Btrc cascade [5]. In colorectal cancer, miR-224 targets Btrc, promoting cell migration and invasion [6]. Exosomal GPT2 from triple-negative breast cancer cells activates Btrc to promote metastasis [7]. Btrc also mediates the degradation of human Lipin-1 [8]. In cardiac senescence, circHIPK3 acts as a scaffold to recruit Btrc to degrade HuR, preventing cardiac senescence [9].

In summary, Btrc, as an E3 ubiquitin ligase, is involved in a wide range of biological processes, including limb development, cancer metastasis, hepatic steatosis, and cardiac senescence. Studies on Btrc using various genetic models, such as the identification of microduplications in human families and functional studies in cells, have provided insights into its role in these disease conditions, highlighting its potential as a therapeutic target.

References:

1. Qiu, Liyan, Li, Caimin, Zheng, Guiyun, Yang, Tuyin, Yang, Fang. 2022. Microduplication of BTRC detected in a Chinese family with split hand/foot malformation type 3. In Clinical genetics, 102, 451-456. doi:10.1111/cge.14204. https://pubmed.ncbi.nlm.nih.gov/35908152/

2. Deng, Rong, Zhang, Hai-Liang, Huang, Jun-Hao, Tang, Jun, Zhu, Xiao-Feng. 2020. MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis. In Autophagy, 17, 3011-3029. doi:10.1080/15548627.2020.1850609. https://pubmed.ncbi.nlm.nih.gov/33213267/

3. Qi, Weiwei, Fang, Zhenzhen, Luo, Chuanghua, Yang, Xia, Gao, Guoquan. . The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase. In Journal of molecular cell biology, 15, . doi:10.1093/jmcb/mjad064. https://pubmed.ncbi.nlm.nih.gov/37873692/

4. Lim, Yvonne Xinyi, Lin, Hexian, Chu, Tinghine, Lim, Yoon Pin. 2021. WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation. In Molecular oncology, 16, 422-446. doi:10.1002/1878-0261.13048. https://pubmed.ncbi.nlm.nih.gov/34197030/

5. Li, Shiyuan, Zeng, Ming, Yang, Lin, Kuang, Manyuan, Li, Jiaying. 2022. Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade. In BMC cancer, 22, 1044. doi:10.1186/s12885-022-10040-5. https://pubmed.ncbi.nlm.nih.gov/36199080/

6. Zheng, Qi, Yu, Jane J, Li, Chenggang, Wang, Jiping, Wang, Shuyang. 2020. miR-224 targets BTRC and promotes cell migration and invasion in colorectal cancer. In 3 Biotech, 10, 485. doi:10.1007/s13205-020-02477-x. https://pubmed.ncbi.nlm.nih.gov/33117626/

7. Cui, Mingqing, Peng, Jiawei, Zhou, Yuanyuan, Wang, Xixi, Cui, Daxiang. 2023. Exosomal GPT2 derived from triple-negative breast cancer cells promotes metastasis by activating BTRC. In Thoracic cancer, 14, 2018-2025. doi:10.1111/1759-7714.14984. https://pubmed.ncbi.nlm.nih.gov/37287397/

8. Ishimoto, Kenji, Hayase, Ayaka, Kumagai, Fumiko, Tachibana, Keisuke, Doi, Takefumi. 2017. Degradation of human Lipin-1 by BTRC E3 ubiquitin ligase. In Biochemical and biophysical research communications, 488, 159-164. doi:10.1016/j.bbrc.2017.04.159. https://pubmed.ncbi.nlm.nih.gov/28483528/

9. Ding, Fengzhi, Lu, Lin, Wu, Chengjie, Yu, Xi-Yong, Li, Yangxin. 2022. circHIPK3 prevents cardiac senescence by acting as a scaffold to recruit ubiquitin ligase to degrade HuR. In Theranostics, 12, 7550-7566. doi:10.7150/thno.77630. https://pubmed.ncbi.nlm.nih.gov/36438474/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest